The role of colonic microbiota amino acid metabolism in gut health regulation
Cell Insight,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100227 - 100227
Published: Jan. 1, 2025
The
human
gut
microbiota
plays
a
critical
role
in
maintaining
host
homeostasis
through
metabolic
activities.
Among
these,
amino
acid
(AA)
metabolism
by
the
large
intestine
is
highly
heterogeneous
and
relevant
to
health.
Despite
increasing
interest,
microbial
AA
remains
relatively
unexplored.
This
review
highlights
recent
advances
colonic
metabolism,
including
auxotrophies,
synthesis,
dissimilatory
metabolites,
their
implications
health,
focusing
on
major
gastrointestinal
diseases
colorectal
cancer,
inflammatory
bowel
disease,
irritable
syndrome.
Language: Английский
Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases
Daiwen Chen,
No information about this author
Caifei Shen,
No information about this author
Xiaorui Zeng
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 31, 2025
The
interplay
between
energy
metabolism
and
the
gut
barrier
is
crucial
for
maintaining
intestinal
physiological
homeostasis.
Energy
perform
distinct
yet
complementary
roles
that
uphold
ecological
equilibrium.
Disruptions
in
can
compromise
integrity
of
barrier;
example,
inactivation
AMPK
pathway
may
lead
to
reduced
expression
proteins
associated
with
tight
junctions.
Conversely,
impairment
result
metabolic
dysregulation,
such
as
alterations
microbiota
impede
production
short-chain
fatty
acids
(SCFAs),
which
are
essential
substrates
metabolism.
This
disruption
affect
modify
gut's
hypoxic
environment.
Imbalances
these
systems
have
been
onset
various
diseases.
Research
indicates
dietary
interventions,
a
low
FODMAP
diet,
enhance
colonization
probiotics
improve
fermentation
SCFAs.
Pharmacological
strategies
elevate
SCFA
levels
activate
rectify
abnormalities
review
provides
comprehensive
summary
recent
advancements
elucidating
interactions
barrier.
Language: Английский
Effects of fructan and gluten on gut microbiota in individuals with self-reported non-celiac gluten/wheat sensitivity—a randomised controlled crossover trial
BMC Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Sept. 4, 2024
Language: Английский
The effects of low FODMAP diet on gut microbiota regulation: A systematic review and meta‐analysis
Panpan Chu,
No information about this author
Ying He,
No information about this author
Fu-Chiang Hu
No information about this author
et al.
Journal of Food Science,
Journal Year:
2025,
Volume and Issue:
90(3)
Published: March 1, 2025
Abstract
This
systematic
review
and
meta‐analysis
aimed
to
evaluate
the
effects
of
a
low
FODMAP
(fermentable
oligosaccharides,
disaccharides,
monosaccharides,
polyols)
diet
on
gut
microbiota
regulation.
A
comprehensive
literature
search
was
conducted
in
PubMed,
Cochrane
Library,
Web
Science,
Embase,
CNKI
(China
National
Knowledge
Infrastructure),
Wanfang
Data
databases.
Randomized
controlled
trials
(RCTs)
comparing
diets
with
normal
were
included.
The
primary
outcome
effect
intestinal
flora.
standardized
mean
difference
(SMD)
95%
confidence
intervals
(CI)
calculated
using
random‐effects
model.
Heterogeneity
assessed
I
2
statistic,
publication
bias
evaluated
funnel
plots
Egger's
test.
Ten
RCTs
involving
590
participants
included
analysis.
showed
significant
positive
flora
compared
(SMD
=
0.33,
CI
[0.01,
0.64],
p
0.003).
Substantial
heterogeneity
observed
(
67.5%).
Subgroup
analysis
irritable
bowel
syndrome
(IBS)
patients
revealed
no
between
0.08,
[−0.17,
0.32],
0.306),
17.0%).
No
detected
(Egger's
test,
0.328).
suggests
that
may
have
However,
appears
be
less
pronounced
IBS
patients.
Further
high‐quality
studies
are
needed
confirm
these
findings
explore
long‐term
impact
health
across
various
gastrointestinal
disorders.
Language: Английский
Therapeutic effects of a Low FODMAP Diet on anxiety in irritable bowel syndrome patients
Hui Tao,
No information about this author
Liuying Li,
No information about this author
Lu Chen
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 7, 2025
Abstract
Background
Individuals
with
Irritable
Bowel
Diseases
(IBS)
have
a
higher
risk
of
mental
disorders.
However,
management
on
IBS
still
focuses
gastrointestinal
symptoms,
often
ignoring
psychological
comorbidities,
which
might
lead
to
suboptimal
therapeutic
outcomes.
The
purpose
the
study
was
investigate
current
state
treatment
at
our
center
and
further
explore
whether
dietary
intervention
could
alleviate
anxiety
burden.
Methods
We
prospectively
enrolled
two
cohorts
patients.
first
one
an
observational
that
designed
assess
prevalence
status
treatment.
other
conducted
efficacy
low
FODMAP
diet
(LFD).
Finally,
stool
samples
were
collected
before
after
LFD
analyzed
by
16s
rRNA
sequencing.
Results
Anxiety
present
in
approximately
60%
patients
cohort
but
consistently
ignored
conventional
therapy.
positively
correlated
discomfort
syndromes.
Rifaximin
only
effective
drug
among
standard
options.
one-month
greatly
both
abdominal
disorders
Though
α-
β-diversity
gut
bacteria
similar
between
responders
non-responders,
composition
dominate
significantly
different.
At
genus
level,
exhibited
abundances
Klebsiella,
Parabacteroides,
Lactobacillus
compared
non-responders.
Conclusions
is
common
patients,
yet
it
frequently
neglected
emerges
as
promising
approach,
potentially
exerting
its
benefits
through
specific
microbiota.
Language: Английский
Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study
Metabolomics,
Journal Year:
2024,
Volume and Issue:
20(2)
Published: Feb. 12, 2024
Abstract
Introduction
There
is
large
variation
in
response
to
diet
irritable
bowel
syndrome
(IBS)
and
determinants
for
differential
are
poorly
understood.
Objectives
Our
aim
was
investigate
clinical
molecular
responses
provocation
with
fermentable
oligo-,
di-,
monosaccharides,
polyols
(FODMAPs)
gluten
individuals
IBS.
Methods
Data
were
used
from
a
crossover
study
week-long
interventions
either
FODMAPs,
or
placebo.
The
also
included
rapid
test.
Molecular
data
consisted
of
fecal
microbiota,
short
chain
fatty
acids,
untargeted
plasma
metabolomics.
IBS
symptoms
evaluated
the
severity
scoring
system.
modelled
against
baseline
questionnaire
data,
using
Random
Forest
(RF;
regression
clustering),
Parallel
Factor
Analysis
(PARAFAC),
univariate
methods.
Results
Regression
classification
RF
models
general
low
predictive
power
(Q
2
≤
0.22,
rate
<
0.73).
Out
864
clustering
models,
only
had
significant
associations
clusters
(0.69
CR
0.73,
p
0.05),
but
no
measures.
Similarly,
PARAFAC
revealed
clear
association
between
metabolome
symptoms.
Conclusion
Differential
FODMAPs
exposures
could
not
be
explained
despite
extensive
exploration
different
analytical
approaches.
trial
registered
at
www.clinicaltrials.gov
as
NCT03653689
31/08/2018.
Language: Английский
The Low-FODMAP Diet, IBS, and BCFAs: Exploring the Positive, Negative, and Less Desirable Aspects—A Literature Review
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(10), P. 2387 - 2387
Published: Sept. 25, 2023
The
literature
about
the
association
of
branched
short-chain
fatty
acids
(BCFAs)
and
irritable
bowel
syndrome
(IBS)
is
limited.
BCFAs,
bacterial
products
catabolism
branched-chain
amino
acids,
are
proposed
as
markers
for
colonic
protein
fermentation.
IBS
a
gastrointestinal
disorder
characterized
by
low-grade
inflammation
intestinal
dysbiosis.
low-FODMAP
diet
(LFD)
has
increasingly
been
applied
first-line
therapy
managing
symptoms,
although
it
decreases
production
(SCFA),
well
known
their
anti-inflammatory
action.
In
parallel,
high
consumption
increases
BCFAs.
Protein
fermentation
alters
microbiome
through
nitrogenous
metabolites
production,
detrimental
effects
on
barrier
promoting
inflammation.
Purpose:
This
review
aims
to
explore
role
BCFAs
gut
in
patients
with
impact
LFD
production.
Methods:
A
search
was
carried
out
using
combination
terms
scientific
databases.
Results:
included
studies
have
contradictory
findings
how
affect
health
patients.
Conclusions:
Although
evidence
suggests
that
may
play
protective
inflammation,
other
associated
Further
research
needed
order
clarify
composition
and,
consequently,
implicated
pathogenesis
or
symptoms
management
LFD+.
Language: Английский
Effects of Short-Term Gluten-Free Diet on Cardiovascular Biomarkers and Quality of Life in Healthy Individuals: A Prospective Interventional Study
Simon de Lange,
No information about this author
Simeon Tsohataridis,
No information about this author
Niklas Boland
No information about this author
et al.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2265 - 2265
Published: July 13, 2024
Introduction:
The
exposome
concept
includes
nutrition
as
it
significantly
influences
human
health,
impacting
the
onset
and
progression
of
diseases.
Gluten-containing
wheat
products
are
an
essential
source
energy
for
world’s
population.
However,
a
rising
number
non-celiac
healthy
individuals
tend
to
reduce
or
completely
avoid
gluten-containing
cereals
health
reasons.
Aim
Methods:
This
prospective
interventional
study
aimed
investigate
whether
short-term
gluten
avoidance
improves
cardiovascular
endpoints
quality
life
(QoL)
in
volunteers.
A
cohort
27
participants
followed
strict
gluten-free
diet
(GFD)
four
weeks.
Endothelial
function
measured
by
flow-mediated
vasodilation
(FMD),
blood
testing,
plasma
proteomics
(Olink®)
QoL
World
Health
Organisation
Quality-of-Life
(WHOQOL)
survey
were
investigated.
Results:
GFD
resulted
decreased
leucocyte
count
C-reactive
protein
levels
along
with
trend
reduced
inflammation
biomarkers
determined
proteomics.
positive
indicated
improvement
FMD,
whereas
other
remained
unchanged.
In
addition,
no
was
observed.
Conclusion:
individuals,
demonstrated
anti-inflammatory
effects
but
did
not
result
overall
enhanced
life.
Language: Английский
Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(11), P. 1649 - 1649
Published: May 27, 2024
There
is
increasing
evidence
indicating
that
changes
in
both
the
composition
and
functionality
of
intestinal
microbiome
are
closely
associated
with
development
several
chronic
inflammatory
diseases,
celiac
disease
(CeD)
being
particularly
noteworthy.
Thanks
to
advent
culture-independent
methodologies,
ability
identify
quantify
diverse
microbial
communities
residing
within
human
body
has
been
significantly
improved.
However,
context
CeD,
a
notable
challenge
lies
characterizing
specific
microbiota
present
on
mucosal
surfaces
intestine,
rather
than
relying
solely
fecal
samples,
which
may
not
fully
represent
relevant
populations.
Currently,
our
comprehension
functional
importance
mucosa-associated
(MAM)
CeD
remains
an
ongoing
field
research
because
limited
number
available
studies
have
reported
few
sometimes
contradictory
results.
MAM
plays
crucial
role
progression
potentially
acting
as
trigger
modulator
immune
response
mucosa,
given
its
proximity
epithelial
cells
direct
interaction.
According
this
background,
review
aims
consolidate
existing
literature
specifically
focused
CeD.
By
elucidating
complex
interplay
between
host
system
gut
microbiota,
we
aim
pave
way
for
new
interventions
based
novel
therapeutic
targets
diagnostic
biomarkers
Language: Английский
DIETA LOW FODMAPS: OPÇÃO DE TRATAMENTO NÃO FARMACOLÓGICO NA SÍNDROME DO INTESTINO IRRITÁVEL
Brazilian Journal of Implantology and Health Sciences,
Journal Year:
2023,
Volume and Issue:
5(5), P. 6287 - 6303
Published: Dec. 24, 2023
A
síndrome
do
intestino
irritável
(SII)
emerge
como
uma
condição
extenuante,
amplamente
disseminada
em
escala
global,
gerando
impactos
significativos
na
qualidade
de
vida
dos
indivíduos
e
nos
custos
associados
à
saúde
pública.
Tendo
vista
que
o
padrão
alimentar
exerce
influência
significativa
modulação
da
microbiota
intestinal,
é
possível
inferir
a
intervenção
dieta
alternativa
viável
para
tratamento
SII.
Dessa
forma,
objetivo
deste
estudo
foi
avaliar
impacto
baixa
FODMAPS
no
Trata-se
revisão
integrativa
literatura
eficácia
adoção
Síndrome
Intestino
Irritável.
low
FODMAPs
tem
se
destacado
abordagem
promissora
manejo
Irritável
(SII).
Ao
restringir
ingestão
determinados
carboidratos
fermentáveis,
essa
estratégia
busca
aliviar
os
sintomas
gastrointestinais
incômodos
SII,
dor
abdominal,
distensão
irregularidades
intestinais.
Embora
apresente
benefícios
notáveis,
são
necessárias
pesquisas
adicionais
compreender
completamente
seus
efeitos
longo
prazo
otimizar
suas
diretrizes,
contribuindo
assim
gestão
mais
eficaz